Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Postpartum Kyleena vs Mirena IUD
NCT03657602Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Dec 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of levonorgestrel intrauterine system in contraception (2 arms), sponsored by University of Oklahoma. Primary endpoint: Expulsion of intrauterine contraception at 10 weeks. Started Dec 2019; status: completed.
02
Drugs
levonorgestrel intrauterine system
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03657602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657602.